# GlaxoSmithKline Consumer Healthcare, LP – FDA Inspection, Jan 9, 2012

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-consumer-healthcare-lp/683b974c-4381-4736-9dde-64c441a01a21
Source feed: FDA_Inspections

> FDA inspection 760651 of GlaxoSmithKline Consumer Healthcare, LP, January 09, 2012. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 760651
- Company Name: GlaxoSmithKline Consumer Healthcare, LP
- Inspection Date: 2012-01-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

Company: https://www.keypedia.com/companies/glaxosmithkline-consumer-healthcare-lp/0e686548-cf93-4039-837a-fe214d86b6e9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c